Paper2593166
Model predicting survival in stage I melanoma based on tumor progression.
Clark WH and 7 others. J Natl Cancer Inst, 1989. Cited by 1,021 papers, by iCite.
Cite this record
ConductScience Library. Model predicting survival in stage I melanoma based on tumor progression. Papers, record 2593166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2593166
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Melanoma | Major topic |
| Female | |
| Humans | |
| Male | |
| Models, Biological | |
| Neoplasm Staging | |
| Probability | |
| Prognosis | |
| Regression Analysis | |
| Survival Rate | |
| Time Factors |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA-16520 | NCI NIH HHS | United States | P01CA016520 | PubMed and NIH | NIH RePORTER |
| CA-25298 | NCI NIH HHS | United States | R01CA025298 | PubMed and NIH | NIH RePORTER |
| CA-25874 | NCI NIH HHS | United States | P01CA025874 | PubMed and NIH | NIH RePORTER |
| P30CA016520 | NIH | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 2313736 | Lymphoid dependency and cutaneous melanoma. | https://conductscience.org/library/papers/2313736 |
Source PubMed
Cited by306
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,021 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42738309 | Hypoxia-Inducible Factor-1α Gene (HIF1A) rs11549465 (1772 C>T) Polymorphism, Body Mass Index, Smoking, and Cutaneous Melanoma: An Observational Case-Control Study. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42738309 | PubMed |
| 42558427 | From biology to morphology and treatment: the current role of pathology in penile cancer - a narrative review. | Front Oncol | 2026 | https://conductscience.org/library/papers/42558427 | PubMed |
| 42516025 | The Prognostic Role of CD8+ Tumor-Infiltrating Lymphocyte Density in Head and Neck Mucosal Melanoma. | Otolaryngol Head Neck Surg | 2026 | https://conductscience.org/library/papers/42516025 | PubMed |
| 42515829 | Spatial T lymphocyte infiltration into the primary melanoma tumor associates with survival. | Melanoma Res | 2026 | https://conductscience.org/library/papers/42515829 | PubMed |
| 42511497 | Association of BRAF Mutation Status with Histopathological Characteristics and Survival Outcomes in Stage II-III Malignant Melanoma. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42511497 | PubMed |
| 42505240 | Interleukin-1β Gene (IL-1B) rs16944 (-511 C > T) Promoter Polymorphism Is Associated with Cutaneous Melanoma Susceptibility, Stage, and Anatomical Localization in a Northern Italian Case-Control Study. | Curr Oncol | 2026 | https://conductscience.org/library/papers/42505240 | PubMed |
| 42457919 | The tumoural landscape of lymphocytes and immune pathways in immunotherapy-treated melanoma patients. | Genes Immun | 2026 | https://conductscience.org/library/papers/42457919 | PubMed |
| 42356028 | Assessment of Risk Factors Correlated with Satellites and In-Transit Metastases in Primary Cutaneous Melanomas. | Medicina (Kaunas) | 2026 | https://conductscience.org/library/papers/42356028 | PubMed |
| 42085373 | EGFR-targeted affibody-polyIC polyplex kills EGFR-overexpressing cancer cells without activating the EGFR. | PLoS One | 2026 | https://conductscience.org/library/papers/42085373 | PubMed |
| 42075611 | Uncovering the Intricate and Heterogeneous Cellular Microenvironment of Cutaneous Melanoma. | Medicina (Kaunas) | 2026 | https://conductscience.org/library/papers/42075611 | PubMed |
| 41893014 | From Immunobiology to Clinical Application: Tumor-Infiltrating Lymphocytes in Melanoma. | J Pers Med | 2026 | https://conductscience.org/library/papers/41893014 | PubMed |
| 41681896 | ABCB5: A Key Regulator Linking Stem Cell Plasticity, Tumor Microenvironment, and Therapy Resistance in Cutaneous Melanoma. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41681896 | PubMed |
| 41604042 | Canine melanomas: MiTF and p38 expression and its correlation with the presence of lymphocytic infiltrate, proliferation, and survival. | Vet Res Commun | 2026 | https://conductscience.org/library/papers/41604042 | PubMed |
| 41576931 | IFNγ-dependent metabolic reprogramming restrains an immature, pro-metastatic lymphatic state in melanoma. | Cancer Cell | 2026 | https://conductscience.org/library/papers/41576931 | PubMed |
| 41559679 | GLUT1 expression, lymphocyte distribution and CD3+ T-cell metabolic subsets as predictive markers of response to immunotherapy in advanced melanoma. | J Exp Clin Cancer Res | 2026 | https://conductscience.org/library/papers/41559679 | PubMed |
| 41249810 | Low GATA3 predicts worse survival in penile cancer. | Sci Rep | 2025 | https://conductscience.org/library/papers/41249810 | PubMed |
| 40941017 | Melanoma Skin Cancer: A Comprehensive Review of Current Knowledge. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40941017 | PubMed |
| 40608341 | Pathologist-Read vs AI-Driven Assessment of Tumor-Infiltrating Lymphocytes in Melanoma. | JAMA Netw Open | 2025 | https://conductscience.org/library/papers/40608341 | PubMed |
| 40595851 | Machine learning to detect melanoma exploiting nuclei morphology and Spatial organization. | Sci Rep | 2025 | https://conductscience.org/library/papers/40595851 | PubMed |
| 40549109 | Tumor-Infiltrating Lymphocyte Therapy for the Treatment of Metastatic Melanoma. | Am J Clin Dermatol | 2025 | https://conductscience.org/library/papers/40549109 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2593166
GET https://conductscience.org/api/papers/v1/2593166/cited_by?page=2